Staining

Polyphor to Present at the UBS Global Healthcare Virtual Conference

Retrieved on: 
Tuesday, May 18, 2021
Bacteriology, Staining, Clinical medicine, Medicine, Eribulin, Macrocycles, Drugs, Antibiotic, Gram-negative bacteria

Polyphor is advancing balixafortide (POL6326) in a Phase III trial in combination with eribulin in patients with advanced breast cancer and exploring its potential in other cancer indications.

Key Points: 
  • Polyphor is advancing balixafortide (POL6326) in a Phase III trial in combination with eribulin in patients with advanced breast cancer and exploring its potential in other cancer indications.
  • In addition, it has discovered and is developing the Outer Membrane Protein Targeting Antibiotics (OMPTA).
  • OMPTA are potentially the first new class of antibiotics in clinical development in the last 50 years against Gram-negative bacteria.
  • Polyphor is based in Allschwil near Basel and is listed on the SIX Swiss Exchange (SIX: POLN).

ContraFect Announces Issuance of Composition of Matter Patent for CF-370 by the United States Patent and Trademark Office

Retrieved on: 
Monday, May 3, 2021
Bacteriology, Medical specialties, Microbiology, Lysin, Staining, Branches of biology, Gram-negative bacteria, Antibiotic, Bacteria

10,988,520 (the \xe2\x80\x98520 patent), on April 27, 2021 for CF-370, the company\xe2\x80\x99s second potential therapeutic product candidate.

Key Points: 
  • 10,988,520 (the \xe2\x80\x98520 patent), on April 27, 2021 for CF-370, the company\xe2\x80\x99s second potential therapeutic product candidate.
  • Gram-negative bacteria have an outer membrane that makes them more resistant to antibiotics.
  • By killing targeted bacteria upon contact, lysins are fundamentally different than conventional antibiotics.\n"With the issuance of this important patent, we continue expanding ContraFect\xe2\x80\x99s strong intellectual property estate covering this new class of antibacterial drugs.
  • CF-370 has been engineered to bypass the outer membrane of the bacteria and to enable potent activity in human serum.

Histology And Cytology Market Size Worth $37.7 Billion By 2028: Grand View Research, Inc.

Retrieved on: 
Monday, April 26, 2021
Biology, Pathology, Staining, Digital pathology, Techniques, Scientific method

b'SAN FRANCISCO, April 26, 2021 /PRNewswire/ -- The global histology and cytology market size is expected to reach USD 37.7 billion by 2028, according to a new report by Grand View Research, Inc.

Key Points: 
  • b'SAN FRANCISCO, April 26, 2021 /PRNewswire/ -- The global histology and cytology market size is expected to reach USD 37.7 billion by 2028, according to a new report by Grand View Research, Inc.
  • The market is expected to expand at a CAGR of 13.1% from 2021 to 2028.
  • For instance, ELITechGroup Inc., in March 2020, launched Aerospray Cytology Slide Stainer Cytocentrifuge.
  • Companies have reported the increasing adoption of digital pathology solutions post COVID-19.\nGrand View Research has segmented the global histology and cytology market based on examination, product, application, and region:\nHistology & Cytology Type Of Examination Outlook (Revenue, USD Million, 2017 - 2028)\n'

Histology And Cytology Market Size Worth $37.7 Billion By 2028: Grand View Research, Inc.

Retrieved on: 
Monday, April 26, 2021
Biology, Pathology, Staining, Digital pathology, Techniques, Scientific method

b'SAN FRANCISCO, April 26, 2021 /PRNewswire/ -- The global histology and cytology market size is expected to reach USD 37.7 billion by 2028, according to a new report by Grand View Research, Inc.

Key Points: 
  • b'SAN FRANCISCO, April 26, 2021 /PRNewswire/ -- The global histology and cytology market size is expected to reach USD 37.7 billion by 2028, according to a new report by Grand View Research, Inc.
  • The market is expected to expand at a CAGR of 13.1% from 2021 to 2028.
  • For instance, ELITechGroup Inc., in March 2020, launched Aerospray Cytology Slide Stainer Cytocentrifuge.
  • Companies have reported the increasing adoption of digital pathology solutions post COVID-19.\nGrand View Research has segmented the global histology and cytology market based on examination, product, application, and region:\nHistology & Cytology Type Of Examination Outlook (Revenue, USD Million, 2017 - 2028)\n'

Your Outdoor Oasis Is One Afternoon Project Away: OLYMPIC Stains by PPG Selects Light Oak as Its First-Ever 2021 Stain Color of the Year

Retrieved on: 
Monday, April 19, 2021
Other Consumer, Home Goods, Women, Manufacturing, Retail, MEN, Landscape, Building Systems, Interior design, Consumer, Other Construction & Property, Architecture, Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, Other Retail, Other Manufacturing, Specialty, Chemicals, Plastics, Skills, Learning, Outdoors, Staining dyes, Wood stain, Pergola, Staining, Deck, Patio, The Great Outdoors, Stain

Homeowners have turned to a wide-range of DIY projects, designing homes that incorporate elements of the great outdoors.\nThis press release features multimedia.

Key Points: 
  • Homeowners have turned to a wide-range of DIY projects, designing homes that incorporate elements of the great outdoors.\nThis press release features multimedia.
  • View the full release here: https://www.businesswire.com/news/home/20210419005521/en/\nLight Oak is a gorgeous, semi-transparent stain color that adds a refined Scandinavian-inspired look, while still allowing the wood\xe2\x80\x99s natural characteristics to shine through.
  • Light Oak can revive outdoor decks, patios and pergolas, blurring the lines between indoor and outdoor living.
  • To find a retailer near you, please use the Olympic Stains by PPG store locator tool .

NAD Finds Certain Claims for Optic White Renewal Toothpaste Supported; Colgate to Appeal Recommendation to Discontinue Quantified Stain Removal Claim

Retrieved on: 
Thursday, March 11, 2021
Chemical substances, Chemistry, Mouth, Dentifrices, Oral hygiene, Teeth, Toothpaste, Household chemicals, Hydrogen peroxide, Staining

However, NAD recommended that Colgate discontinue the claim that its product "removes 10 years of yellow stains."

Key Points: 
  • However, NAD recommended that Colgate discontinue the claim that its product "removes 10 years of yellow stains."
  • In support of its claim that Optic White Renewal "removes 10 years of yellow stains," the advertiser relied on three studies that it sponsored.
  • Accordingly, NAD recommended that the advertiser's claim that Optic White Renewal "removes 10 years of yellow stains" be discontinued.
  • Finally, NAD determined that the advertiser's claim that Optic White Renewal has "the most hydrogen peroxide in a whitening toothpaste" is substantiated.

Landmark Study by Boston Cell Standards Validates First Reference Standards for Immunohistochemistry Testing

Retrieved on: 
Thursday, March 4, 2021
Branches of biology, Biology, Anatomy, Anatomical pathology, Pathology, Immunohistochemistry, Staining, Technical standard, Estrogen receptor

BOSTON, March 04, 2021 (GLOBE NEWSWIRE) -- Boston Cell Standards announced the publication this month of a Canadian national study testing the first reference standard for estrogen receptor (ER) immunohistochemistry (IHC) testing.

Key Points: 
  • BOSTON, March 04, 2021 (GLOBE NEWSWIRE) -- Boston Cell Standards announced the publication this month of a Canadian national study testing the first reference standard for estrogen receptor (ER) immunohistochemistry (IHC) testing.
  • Boston Cell Standards believes that the availability of an ER reference standard will lead to the standardization of ER testing worldwide, ensuring consistent patient test results.
  • Dr. Steven Bogen, CEO of Boston Cell Standards, which developed the reference standard, said, The study data validate our efforts to introduce the same systems of quality assurance to anatomic pathology testing, including reference standards, as already exist in clinical pathology.
  • Boston Cell Standards is the first and only company to develop and manufacture standardized reference materials in the immunohistochemistry industry.

Polyphor to Present Full-Year 2020 Financial Results on March 5

Retrieved on: 
Friday, February 26, 2021
Bacteriology, Branches of biology, Medical specialties, Microbiology, Staining, Gram-negative bacteria, Antibiotic, Bacteria, Forward-looking statement, Pharmaceuticals policy, Veterinary medicine

In addition, it has discovered and is developing the Outer Membrane Protein Targeting Antibiotics (OMPTA).

Key Points: 
  • In addition, it has discovered and is developing the Outer Membrane Protein Targeting Antibiotics (OMPTA).
  • OMPTA are potentially the first new class of antibiotics in clinical development in the last 50 years against Gram-negative bacteria.
  • This press release contains forward-looking statements which are based on current assumptions and forecasts of the Polyphor management.
  • Polyphor disclaims any intention or obligation to update and revise any forward-looking statements, whether as a result of new information, future events or otherwise.

PerkinElmer Launches First Cell Painting Kit

Retrieved on: 
Tuesday, February 16, 2021
Science, Software, Biotechnology, Research, Pharmaceutical, Health, Medical devices, Technology, Biology, Physical sciences, Natural sciences, Molecular biology, Drug discovery, High-content screening, Microscopy, Fluorescence, PerkinElmer, Staining, Antibody, Reagent

PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today launched the first cell painting kit as part of its new portfolio of PhenoVue cellular imaging reagents .

Key Points: 
  • PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today launched the first cell painting kit as part of its new portfolio of PhenoVue cellular imaging reagents .
  • Cell painting is a powerful application of high-content screening technology which combines cell and computational biology to study the effects of perturbagens such as chemical compounds, drugs or genes on the behavior of cells.
  • Helping to address this challenge, the PhenoVue cell painting kit provides convenience and simplicity through a ready-to-use format and is part of a new range of reagents that also includes fluorescent organelle staining probes and dye-labelled secondary antibodies.
  • Researchers are using high-content screening and cell painting to make extraordinary discoveries that will help drive more innovative drugs and therapies, said Alan Fletcher, Vice President and GM of Life Sciences, PerkinElmer.

Minwax® Announces Vintage Blue, a Comforting and Nostalgic Hue, as 2021 Color of the Year

Retrieved on: 
Tuesday, January 26, 2021
Family, Consumer, Other Retail, Parenting, Residential Building & Real Estate, Children, Baby, Maternity, Construction & Property, Specialty, Building Systems, Office Products, Interior design, Fashion, Architecture, Retail, Catalog, Online Retail, Luxury, Other Consumer, Home Goods, Women, MEN, Skills, Staining dyes, Learning, Techniques, Wood stain, Staining, Stain, Wood finishing, Romanowsky stains

1 selling brand* of interior wood stains and clears, announces their first-ever 2021 Color of the Year: Vintage Blue , a comforting organic color with a balance of green and renewing blue.

Key Points: 
  • 1 selling brand* of interior wood stains and clears, announces their first-ever 2021 Color of the Year: Vintage Blue , a comforting organic color with a balance of green and renewing blue.
  • Vintage Blue is the very first Color of the Year from Minwax, inspiring do-it-yourselfers to think of limitless color stain options when planning their next project.
  • Vintage Blue is one of 240-plus color options available in Minwax Wood Finish Water-Based Color Stains , a line of water-based semi-transparent and new-to-the-world solid stains, offering the largest color assortment on the market.
  • In addition to Color Stain, Vintage Blue is available in Minwax Wood Finish Oil-Based Penetrating Stain, exclusively at Lowes stores .